The Handbook of Analysis and Purification of Peptides by RP-HPLC

download The Handbook of Analysis and Purification of Peptides by RP-HPLC

of 36

Transcript of The Handbook of Analysis and Purification of Peptides by RP-HPLC

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    1/36

    The Handbook ofAnalysis and Purification of

    Peptides and Proteins byReversed-Phase HPLC

    Third Edition, 2002

    This handbook presents the basic principles of reversed-phase HPLC for theanalysis and purification of polypeptides. For further details regardingreversed-phase HPLC separations of polypeptides please refer to the technical

    references at the back of the Handbook or contact the Grace Vydac Technical

    Support Group.

    Tab le of Contents

    Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2

    Mechanism of Interaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4

    The Role of the Column in Polypeptide Separations . . . . . . . . . . . . . . . . . . . .8

    Analytical Conditions: The Role of the Mobile Phase and Temperature . . . .17

    Reversed-Phase HPLC/Mass Spectrometry . . . . . . . . . . . . . . . . . . . . . . . . . . .26

    The Role of Reversed-Phase HPLC in Proteomic Analysis . . . . . . . . . . . . . .30

    Examples of the Use of Reversed-Phase HPLC

    in the Analysis of Polypeptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32HPLC as a Tool to Purify and Isolate Polypeptides . . . . . . . . . . . . . . . . . . . .40

    Viral Inactivation During Reversed-Phase HPLC Purification . . . . . . . . . . . .50

    Appendices

    Appendix A: Column Characteristics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52

    Appendix B: The Care and Maintenance of Reversed-Phase Columns . . . . .53

    Appendix C: The Effect of Surfactants on Reversed-Phase Separations . . . .56

    Appendix D: Ion Exchange Chromatography:

    Orthogonal Analytical Techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .58

    Appendix E: The Effect of System Hardwareon Reversed-Phase HPLC Polypeptide Separations . . . . . . . . . . . . . . . . . . . .60

    Technical References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62

    The G race Vyda c Tec hnical Support Group is ava ilable for discussions

    regarding your bio-separation questions.

    Please contact us at:

    Phone 1.800.247.0924 (USA) 1.760.244.6107(International)

    Fax 1.760.244.1984 (USA) 1.888.244.1984 (International)

    www.gracevydac.com

    1

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    2/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    3/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    4/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    5/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    6/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    7/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    8/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    9/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    10/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    11/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    12/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    13/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    14/36

    LC/ MS Uses Short Columnsfor Rapid Analysis

    The trend in LC/MS toward faster

    analyses with reduced resolution

    has led to the use of relatively short

    columns with very fast gradients.

    The trend toward reduced resolutionand faster separations has led to the

    use of short columns packed withsmaller particle adsorbents thannormal. The most commonly usedparticle size in short columns is threemicrometers. Using three micrometercolumns of five to ten centimeterlength with fast gradients enablespolypeptide separations to becompleted in just a few minutes.

    Figure 24 shows the separation offive proteins in less than fiveminutes using a 50 mm longcolumn packed with 3 m particlesusing a fast gradient.

    The development of theelectrospray interface to couple

    mass spectrometry with HPLC hascaused a virtual explosion in theuse of LC/MS in the analysis ofpolypeptides. RP-HPLC peptidemaps are routinely monitored by anon-line mass spectrometer, obtainingpeptide molecular weights andcausing fragmentation of peptides

    to obtain sequence information.

    The combination of mass spectrometrywith HPLC reduces the need forchromatographic resolution becauseof the resolving capacity of the massspectrometer. Analysis times aregenerally short to best utilize thesophisticated mass spectrometer.Detection sensitivity is often muchbetter with mass spectrometry thanwith UV detection.

    Reversed-Phase HPLC/ Mass Spectrometryfor the Analysis of Polypeptides

    To

    Figure 24. Column: C18, 3 m 4.6 x 50 mm (VYDAC 238TP3405).Flow rate: 4.0 ml/min.Eluent: Gradient from 2045% ACN in aqueous 0.1% TFA in 4 min. Sample: protein standards.(1) ribonuclease, (2) insulin, (3) cytochrome c, (4) BSA and (5) myoglobin.

    Rapid Separation of Proteins Using Short (50 mm) Column

    1

    2

    3

    4

    5

    0 1 2 3 4 5

    Minutes

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    15/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    16/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    17/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    18/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    19/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    20/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    21/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    22/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    23/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    24/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    25/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    26/36

    The data in the table belowillustrates that some viruses arehighly inactivated in ethanol(Xenotropic Murie Leukemia Virusand Pseudorabies Virus) while others(Minute Virus of Mice and HumanAdenovirus type 5) are less stronglyinactivated. The combination ofethanol and chromatographic

    separation, however, significantlyreduces the infectivity level of allfour viruses.

    Reversed-phase HPLC usuallyreduces or eliminates viral

    activity in protein preparations,making it a valuable step inrecombinant protein purification.Viral inactivation occurs throughtwo mechanisms. First, exposure toethanol inactivates many viruses.Second, viruses can be separated

    from protein in the chromatographicstep (see Figure 47).

    Viral inactivation by ethanol and chrom

    Log10 infectivity reduction by exposure to or a combination of ethanol and chromato

    XmuLV

    Ethanol exposure >4.9.13RP-HPLC in ethanol >5.9

    XMuLVXenotropic Murine LeukemiaMVMMinute Virus of Mice

    Adeno5Human adenovirus type 5

    PRVPseudorabies Virus

    Figure 47. Separation of Xenotropic Murine Leukemia Virus (XMuLV) from target protein during preparative HPLC.Column: VYDAC C

    4, 20-30 mmElution: Ethanol gradient

    Data courtesy of Holly Harker and Marcus Luscher, Amgen, Boulder, Colorado

    Separation of Xenotropic Murine Leukemia Virus

    XMuLV Viruswas detectedin this peak

    XMuLV Viruswas below the

    limit of detectionin this peak

    300

    200

    100

    00 50 100 150 200 mL

    Ethanol Gradient

    mau

    Viral Inactivation DuringReversed-Phase HPLC Purification

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    27/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    28/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    29/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    30/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    31/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    32/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    33/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    34/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    35/36

  • 8/3/2019 The Handbook of Analysis and Purification of Peptides by RP-HPLC

    36/36

    70

    About the author

    David Carr, a graduate of U.C. Berkeley, first became involved in HPLC

    in 1971, when the technique was in its infancy. As the technical marketing

    manager of Vydac from 19841996, David was involved in the use of

    reversed-phase HPLC for protein and peptide separations for both analytical

    and preparative purposes. Working with companies such as Genentech,

    Amgen, and Immunex, David assisted in developing protein and peptide

    separation methods for quality control as well as consulting on large-scale

    preparative separations. Since 1996 David has developed and instructed

    courses in analytical biotechnology and HPLC. His short course, Fundamentals

    in Analytical Biotechnology, is very popular among biotechnology companies

    (details may be found at www.bioanalyticaltech.com ). David is the author of

    the first two editions ofThe Handbook of the Analysis and Purification

    of Peptides and Proteins by Reversed-Phase HPLCas well as this, the

    Third Edition.

    Hesperia, Ca lifornia, USAISO m anufact uring, research and

    developme nt, app lications and shipping

    The Sepa rations Group

    17434 Moja ve Street

    Hesperia , CA 92345 USA

    Phone: (800) 247-0924 or (760) 244-6107

    Fax: ( 888) 244-6610 or (760) 244-1984

    Columbia, Maryland, USAExecut ive offices,sales and m arketing

    manag ement, and separations research

    W.R.Grace & Co.Conn.

    7500 Grace Drive

    Colum bia, MD 21044 USA

    Phone: (410) 531-4000

    Toll Free : (800) 638-6014

    Fax: (410) 531-4273

    Baltimore, Maryland, USAISO m anufact uring and shipping

    W.R.Grace & Co.Conn.

    5500 Chemical Road

    Baltimore, MD 21226 USA

    Phone: (410) 355-4900

    Fax: (410) 354-8945

    Worms, GermanySepa rations research and ISO man ufac turing

    Grace GmbH & Co. KG

    In der Hollerhecke 1

    67545 Worms,G erma ny

    Phone: (49) 6241 403 0

    Fax: ( 49) 6241 403 211

    Customer a nd Tec hnical Service17434 Moja ve Street

    Hesperia , Ca lifornia 92345

    Phone: 760-244-6107

    Fax: 760-244-1984

    On-lineexperts@vydac .com

    www.gracevydac.com

    The information contained he rein isb ased on our testing and experienc e and iso ffered for the users consideration, investigationand verification. Since ope rating and use cond itionsvary and since we d o not c ontrol such c ondiitions,w e must DISCLAIMANY WARRANTY,EXPRESSED OR IMPLIED,w ith regard t o resultsto b e ob taine d from the use of this prod uct. Test metho ds are

    available o n request. 2002 W.R.Grac e & Co.-Conn.All rightsreserved.VYDAC isa registered trade mark of The SeparationsGroup,a wholly-owned subsidiary of W.R.Grace & Co .Conn.